DNTH vs PVLA โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
DNTH Captures Institutional Edge (2โ1 Pillars ยท 4โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Dianthus Therapeutics, Inc. Common Stock (DNTH) driven by superior Growth & Margin, Options & Structure while PVLA counters with relative strength in Momentum & Technical. Fundamentally, DNTH trades at N/M Forward P/E with -8683.9% operating margin (+205.6% YoY revenue) versus PVLA at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, DNTH sits in CONSOLIDATION (7th %ile IV; Dealer Gamma Walls on Pro) against PVLA sits in CONSOLIDATION (2nd %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | DNTH Revenue | PVLA Revenue | DNTH Op. Margin | PVLA Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | N/A | $30M | N/A | -113.1% | PVLA |
| FY2019 | N/A | $40M | N/A | -62.2% | PVLA |
| FY2020 | N/A | $30M | N/A | -115.7% | PVLA |
| FY2021 | N/A | $30M | N/A | -165.0% | PVLA |
| FY2022 | N/A | $30M | N/A | -167.8% | PVLA |
| FY2023 | $0M | $40M | -1704.7% | -27.7% | PVLA |
| FY2024 | $10M | N/A | -1633.7% | N/A | DNTH |
| FY2025 | $0M | N/A | -8739.3% | N/A | DNTH |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | DNTH | PVLA | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $5.2B | $2.2B | Larger Scale | DNTH |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +205.6% | +0.0% | Higher Growth | DNTH |
| Operating Margin (TTM) Profitability | -8683.9% | 0.0% | Higher Margin | PVLA |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -22.6% | -63.4% | Higher ROE | DNTH |
| 52-Week Range Position Momentum | 65% ($34โ$118) | 68% ($72โ$180) | Stronger Trend | PVLA |
| Beta / 30D Volatility Risk Regime | 1.03ฮฒ ยท 41% Vol | 1.66ฮฒ ยท 75% Vol | Lower Realized Risk | DNTH |
| Unified Institutional Score Composite Signal | 34.1 / 100 (SELL) | 48.2 / 100 (HOLD) | Higher Composite | PVLA |